THOMAS K SLIGH
Allopathic & Osteopathic Physicians|Internal Medicine VICKSBURG, MS NPI 1811928005
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MS GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$958.35
- Category: General Payments
- Program years: PY2018–2024
- Record count: 63
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $136.74 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $136.74 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $36.23 | 2 |
| Lilly USA, LLC | $33.47 | 2 |
| Novo Nordisk AS | $29.49 | 2 |
| Exact Sciences Corporation | $23.59 | 1 |
| Abbott Laboratories | $13.96 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096618800 | Novo Nordisk Inc | $14.10 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096648366 | Novo Nordisk Inc | $15.39 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114904135 | Exact Sciences Corporation | $23.59 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116247638 | GlaxoSmithKline, LLC. | $18.31 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116534872 | GlaxoSmithKline, LLC. | $17.92 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125286538 | Abbott Laboratories | $13.96 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135463664 | Lilly USA, LLC | $13.67 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135464740 | Lilly USA, LLC | $19.80 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.